Highly expressed P-gp in lymphocytes has been demonstrated to be involved in mechanisms of glucocorticoid insensitivity or resistance in several immune diseases besides SLE, including asthma, inflammatory bowel disease, immune thrombocytopenia and rheumatoid arthritis (RA) (16,22–26). This evidence concerns the gene PGP and immune system disorder.